Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mark D, Vincent"'
Autor:
Beatrice T. B. Preti, Michael S. Sanatani, Daniel Breadner, Suganija Lakkunarajah, Carolyn Scott, Caroline Esmonde-White, Eric McArthur, George Rodrigues, Mitali Chaudhary, Adam Mutsaers, Robin Sachdeva, Mark D. Vincent
Publikováno v:
Current Oncology, Vol 30, Iss 8, Pp 7713-7721 (2023)
The 2017 PACIFIC trial heralded the incorporation of routine adjuvant durvalumab following curative-intent chemoradiation for stage III non-small-cell lung cancer (NSCLC). However, carefully selected clinical trial populations can differ significantl
Externí odkaz:
https://doaj.org/article/73cd1d24ee9a4597a4ec6f0acd5c70a5
Autor:
Richard A. Malthaner, Edward Yu, Michael Sanatani, Debra Lewis, Andrew Warner, A. Rashid Dar, Brian P. Yaremko, Joel Bierer, David A. Palma, Dalilah Fortin, Richard I. Inculet, Eric Fréchette, Jacques Raphael, Stewart Gaede, Sara Kuruvilla, Jawaid Younus, Mark D. Vincent, George B. Rodrigues
Publikováno v:
Thoracic Cancer, Vol 13, Iss 13, Pp 1898-1915 (2022)
Abstract Background We compared the health‐related quality of life (HRQOL) in patients undergoing trimodality therapy for resectable stage I‐III esophageal cancer. Methods A total of 96 patients were randomized to standard neoadjuvant cisplatin a
Externí odkaz:
https://doaj.org/article/3b12890c920c426ab850df2b1fe0356a
Autor:
Edward Yu, Alison L. Allan, Michael Sanatani, Debra Lewis, Andrew Warner, A. Rashid Dar, Brian P. Yaremko, Lori E. Lowes, David A. Palma, Jacques Raphael, Mark D. Vincent, George B. Rodrigues, Dalilah Fortin, Richard I. Inculet, Eric Frechette, Joel Bierer, Jeffery Law, Jawaid Younus, Richard A. Malthaner
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Our aim was to establish if presence of circulating tumor cells (CTCs) predicted worse outcome in patients with non-metastatic esophageal cancer undergoing tri-modality therapy. Methods We prospectively collected CTC data from pat
Externí odkaz:
https://doaj.org/article/8cb2db1ff05644bd83701d5be8c74a0a
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 1189-1193 (2021)
This case discusses a 62-year-old woman with de novo metastatic lung adenocarcinoma (PD-L1 >50% with a KRAS G12C mutation, ALK and EGFR negative) who was on pembrolizumab for 1 year without any significant toxicity, only low-grade dermatitis and hypo
Externí odkaz:
https://doaj.org/article/b49e0bb04f7a4f9698e99c787f282971
Autor:
Athel Cornish-Bowden, David Rasnick, Henry H. Heng, Steven Horne, Batoul Abdallah, Guo Liu, Christine J. Ye, Mathew Bloomfield, Mark D. Vincent, C. Marcelo Aldaz, Jenny Karlsson, Anders Valind, Caroline Jansson, David Gisselsson, Jennifer A. Marshall Graves, Aleksei A. Stepanenko, Svitlana V. Andreieva, Kateryna V. Korets, Dmytro O. Mykytenko, Nataliya L. Huleyuk, Vladimir P. Baklaushev, Oksana A. Kovaleva, Vladimir P. Chekhonin, Yegor S. Vassetzky, Stanislav S. Avdieiev, Bjorn Bakker, Aaron S. Taudt, Mirjam E. Belderbos, David Porubsky, Diana C. J. Spierings, Tristan V. de Jong, Nancy Halsema, Hinke G. Kazemier, Karina Hoekstra-Wakker, Allan Bradley, Eveline S. J. M. de Bont, Anke van den Berg, Victor Guryev, Peter M. Lansdorp, Maria Colomé Tatché, Floris Foijer, Thomas Liehr, Nicolaas C. Baudoin, Joshua M. Nicholson, Kimberly Soto, Isabel Quintanilla, Jordi Camps, Daniela Cimini, M. Dürrbaum, N. Donnelly, V. Passerini, C. Kruse, B. Habermann, Z. Storchová, Daniele Mandrioli, Fiorella Belpoggi, Ellen K Silbergeld, Melissa J Perry, Rolf I. Skotheim, Marthe Løvf, Bjarne Johannessen, Andreas M. Hoff, Sen Zhao, Jonas M. SveeStrømme, Anita Sveen, Ragnhild A. Lothe, R. Hehlmann, A. Voskanyan, A. Fabarius, Alfred Böcking, Stefan Biesterfeld, Leonid Berynskyy, Christof Börgermann, Rainer Engers, Josef Dietz, A. Fritz, N. Sehgal, J. Vecerova, B. Stojkovicz, H. Ding, N. Page, C. Tye, S. Bhattacharya, J. Xu, G. Stein, J. Stein, R. Berezney, Xue Gong, Sarah Grasedieck, Julian Swoboda, Frank G. Rücker, Lars Bullinger, Jonathan R. Pollack, Fani-Marlen Roumelioti, Maria Chiourea, Christina Raftopoulou, Sarantis Gagos, Peter Duesberg, Mat Bloomfield, Sunyoung Hwang, Hans Tobias Gustafsson, Ciara O’Sullivan, Aracelli Acevedo-Colina, Xinhe Huang, Christian Klose, Andrej Schevchenko, Robert C. Dickson, Paola Cavaliere, Noah Dephoure, Eduardo M. Torres, Martha R. Stampfer, Lukas Vrba, Mark A. LaBarge, Bernard Futscher, James C. Garbe, Yi-Hong Zhou, Andrew L. Trinh, Michelle Digman
Publikováno v:
Molecular Cytogenetics, Vol 10, Iss S2, Pp 77-94 (2017)
Externí odkaz:
https://doaj.org/article/b6866d4289674f288bf6c946e8f882e4
Autor:
Brian P, Yaremko, Dante P I, Capaldi, Khadija, Sheikh, David A, Palma, Andrew, Warner, A Rashid, Dar, Edward, Yu, George B, Rodrigues, Alexander V, Louie, Mark, Landis, Michael, Sanatani, Mark D, Vincent, Jawaid, Younus, Sara, Kuruvilla, Jeff Z, Chen, Abigail, Erickson, Stewart, Gaede, Grace, Parraga, Douglas A, Hoover
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 113:1072-1084
To determine whether functional lung avoidance based onPatients with stage III non-small cell lung cancer (or oligometastatic disease treated with curative intent) undergoing CCRT with at least a 10 pack-year smoking history were eligible. Patients u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dadbd23780f9aff00eb7dc7feed3a2ec
https://doi.org/10.1016/j.ijrobp.2022.04.047
https://doi.org/10.1016/j.ijrobp.2022.04.047
Autor:
Daniel A, Breadner, Mark D, Vincent, Rohann, Correa, Morgan, Black, Andrew, Warner, Michael, Sanatani, Vasudeva, Bhat, Clive, Morris, Greg, Jones, Alison, Allan, David A, Palma, Jacques, Raphael
Publikováno v:
Lung Cancer. 165:145-151
Blood-based liquid biopsies examining circulating tumour DNA (ctDNA) have increasing applications in non-small cell lung cancer (NSCLC). Limitations in sensitivity remain a barrier to ctDNA replacing tissue-based testing. We hypothesized that testing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1786d6a5b6f2a3c30a4116cd5d150a59
https://doi.org/10.1016/j.lungcan.2022.01.013
https://doi.org/10.1016/j.lungcan.2022.01.013
Autor:
Gregory MM Videtic, Pauline T Truong, Robert B Ash, Edward W Yu, Walter I Kocha, Mark D Vincent, Anna T Tomiak, A Rashid Dar, Frances Whiston, Larry W Stitt
Publikováno v:
Canadian Respiratory Journal, Vol 12, Iss 5, Pp 245-250 (2005)
PURPOSE: To look for survival differences between men and women with limited stage small cell lung cancer (LS-SCLC) by examining stratified variables that impair treatment efficacy.
Externí odkaz:
https://doaj.org/article/2e51080284264caf8be130b20a434053
Autor:
Peter J. Ferguson, Mark D. Vincent, Yousef Najajreh, Brian Shilton, Stephen Ritter, Rima Al-awar, Richard Marcellus, Mohammed Mohammed, Methvin Isaac, James Koropatnick
Publikováno v:
Cancer Research. 82:346-346
The inherent genetic instability of cancer cells and the dependence of many tumor types on oncogenic drivers contribute selectivity of anticancer agents against tumor cells. That selectivity is limited, and toxicity to normal cells remains a major li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a3a5d42c425108a3377f9957aa34fb6
https://doi.org/10.1158/1538-7445.am2022-346
https://doi.org/10.1158/1538-7445.am2022-346
Publikováno v:
Canadian Respiratory Journal, Vol 10, Iss 3, Pp 143-144 (2003)
A 64-year-old man was diagnosed with unresectable cancer of the trachea. He was treated definitively with a novel chemoradiation regimen. Cisplatin-based chemotherapy (ChT) was given for two cycles as induction, followed by concurrent administration
Externí odkaz:
https://doaj.org/article/15fe407ad84147c580efc7a5d282a375